技術指標
指標
數值
方向
MACD(12,26,9)
-0.022
賣出
RSI(14)
32.676
中性
STOCH(KDJ)(9,3,3)
20.459
買入
ATR(14)
0.047
高波動
CCI(14)
-80.530
中性
Williams %R
82.170
超賣
TRIX(12,20)
-1.294
賣出
StochRSI(14)
100.000
買入
搜尋
cbdMD Inc
YCBD添加自選
0.509USD
+0.038+8.05%
收盤 07-31 16:00（美東）報價延遲15分鐘
5.12M總市值
0.02本益比TTM
關鍵數據
0.490今開
0.534最高
161.43K成交量
0.02本益比TTM
虧損本益比動
--股利TTM
1.60%換手率
0.471昨收
0.480最低
60.64K成交額
虧損本益比靜
0.57市淨率
0.00%股息率 TTM
-22.91%ROA
2.56052週最高
0.72量比
-7.70M淨利潤
10.07M總股本
28.1293每股盈餘TTM
2.15Beta
-62.55%ROE
0.47052週最低
11.49%振幅
53.29%毛利率
5.12M總市值
-3.53回報/風險
8.85%風險率
TradingKey cbdMD Inc股票評分
單位: USD 更新時間: 2026-07-31操作建議
cbdMD Inc當前公司基本面數據相對健康，增長潛力很大。當前估值合理，在藥品行業排名68/155位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為2.00。中期看，股價處於下降通道。近一個月，市場表現非常差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
cbdMD Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看好
cbdMD Inc亮點
亮點風險
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
業績增長期
公司處於發展階段，最新年度總收入19.19M美元
估值高估
公司最新PE估值0.02，處於3年歷史高位
分析師目標
基於
1
分析師
買入
評級
2.000
目標均價
+309.00%
漲幅空間
cbdMD Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
1
分析師
買入
評級
2.000
目標均價
+309.00%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
160
總數
6
中位數
9
平均值
公司名稱
評級分佈
分析師數
cbdMD Inc
YCBD
1
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
34
艾伯維
ABBV
33
輝瑞
PFE
32
1
2
3
...
32
技術指標
移動平均線
指標
數值
方向
MA5
0.497
買入
MA10
0.532
賣出
MA20
0.614
賣出
MA50
0.677
賣出
MA100
0.731
賣出
MA200
0.832
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
cbdMD Inc簡介
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
公司代碼YCBD
公司cbdMD Inc
CEOKennedy (T. Ronan)
網址https://www.cbdmd.com/
公司股東
相關品種
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
cbdMD Inc(YCBD)的當前股價是多少？
cbdMD Inc(YCBD)的當前股價是 0.51。
cbdMD Inc 的股票代碼是什麼？
cbdMD Inc的股票代碼是YCBD。
cbdMD Inc股票的52週最高點是多少？
cbdMD Inc股票的52週最高點是2.56。
cbdMD Inc股票的52週最低點是多少？
cbdMD Inc股票的52週最低點是0.47。
cbdMD Inc的市值是多少？
cbdMD Inc的市值是5.12M。
現在cbdMD Inc(YCBD)的股票是買入、持有還是賣出？
根據分析師評級，cbdMD Inc(YCBD)的總體評級為買入，目標價格為2.00。
cbdMD Inc(YCBD)股票的每股收益（EPS TTM）是多少
cbdMD Inc(YCBD)股票的每股收益（EPS TTM）是-1.09。